Inclusion Criteria:  Age ≥18 years; Diagnosis of spontaneous ICH, confirmed by brain imaging; Presentation within 48 hours of symptom onset (or last seen well); Meet any of the following criteria: a) NIHSS ≥8, or b) GCS 7-14; Provide written informed consent by patient (or approved surrogate);  Exclusion Criteria:  ICH secondary to a structural abnormality in the brain (e.g. cerebrovascular malformation, arterial aneurysm, tumour, Moyamoya disease, trauma, or previous ischaemic stroke), or secondary to presumed cerebrovascular amyloidosis, or secondary to reperfusion treatment for ischaemic stroke, or secondary to anticoagulant treatment, or secondary to antiplatelet treatment. Unlikely to potentially benefit from therapy (e.g. advanced dementia) or judged by responsible treating clinician to have a high likelihood of early death irrespective of treatment; Other medical illness that will interfere with outcome assessments and follow-up (e.g. known significant pre-stroke disability [modified Rankin scale {mRS} scores 4-5], advanced cancer and renal failure); Known definite contraindication to the Chinese herbal medicine; Women who are known to be pregnant or lactating; Currently participating in another trial which would interfere with outcome assessments.